Market Risers: Applied Graphene Materials, Ashtead Group, AstraZeneca, Barratt Developments

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

The share price for Applied Graphene Materials with EPIC code: LON:AGM has stepped up 3.89% or 1.48 points throughout the session so far. Investors seem confident during the session. The periods high has reached 40.5 dipping to 38.32. The volume total for shares traded up to this point was 95,970 with the daily average number around 335,553. The 52 week high is 53 about 15 points in difference to the previous days close of business and a 52 week low sitting at 7 making a difference of 31 points. Applied Graphene Materials now has a 20 moving average of 35.36 and now its 50 day moving average at 26.93. The current market capitalisation is £19.51m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Applied Graphene Materials being recorded at Monday, September 7, 2020 at 12:12:25 PM GMT with the stock price trading at 39.48 GBX.

The stock price for Ashtead Group with ticker code: LON:AHT has risen 4.3% or 110 points in today’s trading session so far. Market buyers have remained positive throughout the trading session. The periods high has reached 2675.39 meanwhile the session low reached 2585. The number of shares traded by this point in time totalled 265,996 with the daily average traded share volume around 865,293. The 52 week high for the shares is 2879 which comes in at 318 points different to the previous business close and a 52 week low sitting at 1010 which is a difference of 1551 points. Ashtead Group now has a 20 moving average of 2721.8 and the 50 day simple moving average now at 2685.51. The market capitalisation currently stands at £12,001.07m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Ashtead Group being recorded at Monday, September 7, 2020 at 12:32:07 PM GMT with the stock price trading at 2671 GBX.

The share price for AstraZeneca ticker lookup code: LON:AZN has increased 3.35% or 267 points during today’s session so far. Buyers have remained optimistic throughout the session. The periods high has reached 8243.74 meanwhile the session low reached 8043. The amount of shares exchanged has so far reached 299,513 with the daily average number around 1,649,721. A 52 week high for the stock is 10120 which is 2150 points different to the previous business close and a 52 week low sitting at 5871 a difference of some 2099 points. AstraZeneca has a 20 SMA of 8563.08 with a 50 day moving average now of 8708.66. The current market capitalisation is £108,093.14m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca being recorded at Monday, September 7, 2020 at 12:32:10 PM GMT with the stock price trading at 8237 GBX.

The share price for Barratt Developments with EPIC code: LON:BDEV has gained 3.71% or 18.6 points throughout today’s trading session so far. Traders have stayed positive during the trading session. The periods high has reached 522.8 dipping to 504.2. The total volume of shares traded by this point was 1,359,551 whilst the average number of shares exchanged is 3,357,357. The 52 week high for the shares is 889.2 some 387.4 points in difference to the previous days close of business and a 52 week low sitting at 349.4 which is a difference of 152.4 points. Barratt Developments has a 20 day moving average of 528.78 and now a 50 day moving average now of 530.69. This puts the market capitalisation now at £5,299.28m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Barratt Developments being recorded at Monday, September 7, 2020 at 12:32:02 PM GMT with the stock price trading at 520.4 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.

Search

Search